Immune effects of escalating doses of granulocyte-macrophage colony-stimulating factor added to a fixed, low-dose, inpatient interleukin-2 regimen: a randomized phase I trial in patients with metastatic melanoma and renal cell carcinoma (Q44342919)
Jump to navigation
Jump to search
scientific article published in March 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immune effects of escalating doses of granulocyte-macrophage colony-stimulating factor added to a fixed, low-dose, inpatient interleukin-2 regimen: a randomized phase I trial in patients with metastatic melanoma and renal cell carcinoma |
scientific article published in March 2003 |
Statements
1 reference
Immune effects of escalating doses of granulocyte-macrophage colony-stimulating factor added to a fixed, low-dose, inpatient interleukin-2 regimen: a randomized phase I trial in patients with metastatic melanoma and renal cell carcinoma (English)
1 reference
John W Smith II
1 reference
Robert A Kurt
1 reference
Angelo G Baher
1 reference
Susan Denman
1 reference
Lisa Justice
1 reference
Teri Doran
1 reference
Mark Gilbert
1 reference
W Gregory Alvord
1 reference
Walter J Urba
1 reference
1 March 2003
1 reference
1 reference
Identifiers
1 reference